bs-0181R-A350 [Conjugated Primary Antibody]
Nociceptin receptor Polyclonal Antibody, ALEXA FLUOR® 350 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: Nociceptin receptor

Immunogen Range: 1-47/370

Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 18389

Swiss Prot: P35377

Source: KLH conjugated synthetic peptide derived from mouse Nociceptin receptor

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.

Storage Condition: Store at 4°C for 12 months.

Background: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.

Conjugation: ALEXA FLUOR® 350

Excitation/ Emission: 343nm/442nm

Size: 100ul

Concentration: 1ug/ul

Applications: IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)

Cross Reactive Species: Human
Mouse
Rat

Predicted Cross Reactive Species: Dog
Cow
Pig
Horse
Guinea Pig

For research use only. Not intended for diagnostic or therapeutic use.

VALIDATION IMAGES

Formalin-fixed and paraffin embedded human placenta tissue labeled with Rabbit Anti-Nociceptin receptor Polyclonal Antibody (bs-0181R) at 1:200 followed by conjugation to the secondary antibody and DAPI staining.


Formalin-fixed and paraffin embedded human placenta tissue labeled with Rabbit Anti-Nociceptin receptor Polyclonal Antibody (bs-0181R) at 1:200 followed by conjugation to the secondary antibody.